Missing content? – Request curation!
Request curation for specific Genes, variants, or PubMed publications.
Have questions, comments or suggestions? - Let us know!
Email us at : firstname.lastname@example.org
JNJ-78306358 is a bispecific antibody that targets HLA-G expressed on tumor cells and the T-lymphocyte antigen CD3, potentially leading to activation of a cytotoxic T-lymphocyte response against tumor cells (NCI Drug Dictionary).
|DrugClasses||CD3 Antibody 59|
|CAS Registry Number||NA|
|Therapy Name||Drugs||Efficacy Evidence||Clinical Trials|